Global Phytopathological Disease Diagnostics Market, By Product (Kits, Accessories, Other Consumables), By Test (PCR-Based Assays, Isothermal Amplification Assays, Serological Tests, Others), By End-User (Academic and Research Institutes, Food Processing Laboratories, Others), and opportunities and forecast 2020-2027.
The global Phytopathological Disease Diagnostics market is expected to rise at a considerable rate in the forecast period. Various types of diseases and infections affect the growth and development of multiple plant species. Also, the increasing focus of the herbal and medical industries on preserving important plant species has created the need for the diagnosis of plant disease. This key factor majorly contributes to the growth of the global Phytopathological Disease Diagnostics market. In addition to this, advancements in botanical studies, herbal medications, and plant-based food manufacturing are further expanding the growth of the Phytopathological Disease Diagnostics market.
Furthermore, progressions in genomic research have yielded positive results for the vendors operating in the global phytopathological disease diagnostics market. In addition, the use of several types of test assays to understand plant diseases has also created new opportunities for market expansion. Additionally, the importance of serological testing across academic and research laboratories is further supports the growth of the market. Again, in the next few years, the use of plant disease diagnostics in the domain of food processing and disease analysis will increase to a great extent.
Moreover, plant diseases destroying large habitats of various plants, which affect the biodiversity of a region. Hence, phytopathological disease diagnostics not only preserve medication plants but also preserve the biodiversity of dense forests. In addition to this, infections and abiotic disorders in plants can destroy large areas of vegetation. All these factors are significantly contributing to the development of the Phytopathological Disease Diagnostics market.
Based on the test, the PCR-Based Assays segment has significant growth in the market. PCR-based molecular diagnostic tests are progressively being used to guide phytopathological disease diagnostics. The high specificity, sensitivity, and low sample requirement make PCR-based molecular assay a go-to technique for clinical diagnosis. In addition, PCR-based molecular assays are becoming the primary mode of diagnosis for the detection of pathogens in case of a rapid disease outbreak. This trend is mainly due to the low or non-availability of rapid or specific diagnostic tests for several plant diseases. Relating to extensive applications of PCR in the field of disease diagnostics, this segment is expected to register high growth during the forecast period.
Phytopathological Disease Diagnostics Market, By Product
· Kits · Accessories · Other Consumables
Phytopathological Disease Diagnostics Market, By Test
Region-wise, North America Dominates the global Phytopathological Disease Diagnostics market. This can be attributed to the increasing prevalence of phytopathological disorders and favorable R&D initiatives in this region. Additionally, the presence of sophisticated diagnostic laboratories and the high acceptance rate of novel assay technologies are further accelerating the growth of the market. In recent years, several government initiatives were launched, which are enhancing the growth of the market in this region.
Phytopathological Disease Diagnostics Market, By Geography
· North America (US & Canada) · Europe (UK, Germany, France, Italy, Spain, Russia & Rest of Europe) · Asia-Pacific (Japan, China, India, Australia, & South Korea, & Rest of Asia-Pacific) · LAMEA (Brazil, Saudi Arabia, UAE & Rest of LAMEA)
Some key developments and strategies adopted by manufacturers in Phytopathological Disease Diagnostics are highlighted below.
· In May 2021, Penn State and U.S. Department of Agriculture scientists have used cutting-edge CRISPR/Cas technology to develop a diagnostic test that could enable early diagnosis of citrus greening, or Huanglongbing, a serious disease that threatens worldwide citrus production, which is valued at roughly $17 billion from the sale of fresh fruit and juices.